Literature DB >> 20351093

MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.

Ronald T K Pang1, Carmen O N Leung, Tian-Min Ye, Weimin Liu, Philip C N Chiu, Kevin K W Lam, Kai-Fai Lee, William S B Yeung.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that regulate the expression of other genes by transcriptional inhibition or translational repression. miR-34a is a known tumor suppressor gene and inhibits abnormal cell growth. However, its role in other tumorigenic processes is not fully known. This study aimed to investigate the action of miR-34a on cell invasion. We found that miR-34a is expressed at various levels in cervical cancer (HeLa, SiHa, C4I, C33a and CaSki) and trophoblast (BeWo and JAR) cell lines. Transient forced expression of miR-34a did not affect the proliferation of these cell lines. Computational miRNA target prediction suggested that Notch1 and Jagged1 were targets of miR-34a. By using functional assays, miR-34a was demonstrated to bind to the 3' untranslated regions of Notch1 and Jagged1. Forced expression of miR-34a altered the expression of Notch1 and Jagged1 protein as well as Notch signaling as shown by the response of Hairy Enhancer of Split-1 protein to these treatments using western blot analysis. Forced expression of miR-34a suppressed the invasiveness of HeLa and JAR cells. By using gamma-secretase inhibitor (N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester) that interfered Notch signaling and RNA interference that knockdown Notch1 expression, we confirmed that downregulation of Notch1 reduced the invasiveness of the cells. Transfection of intracellular domain of Notch nullifies the effect of miR-34a on the invasiveness of the cells. Besides, we identified that miR-34a affected cell invasion by regulating expression of urokinase plasminogen activator through Notch. Our results provide evidence that miR-34a inhibits invasiveness through regulation of the Notch pathway and its downstream matrix degrading enzyme.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351093     DOI: 10.1093/carcin/bgq066

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  115 in total

1.  MicroRNA-34a modulates cytoskeletal dynamics through regulating RhoA/Rac1 cross-talk in chondroblasts.

Authors:  Dongkyun Kim; Jinsoo Song; Sunhyo Kim; Hyang Mi Park; Churl-Hong Chun; Jongkyung Sonn; Eun-Jung Jin
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

Review 2.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

Review 3.  The emerging functions of the p53-miRNA network in stem cell biology.

Authors:  Chao-Po Lin; Yong Jin Choi; Geoffrey G Hicks; Lin He
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

4.  miR-34a expression, epigenetic regulation, and function in human placental diseases.

Authors:  Ludivine Doridot; Dorothée Houry; Harald Gaillard; Sonia T Chelbi; Sandrine Barbaux; Daniel Vaiman
Journal:  Epigenetics       Date:  2013-09-30       Impact factor: 4.528

Review 5.  Minireview: The roles of small RNA pathways in reproductive medicine.

Authors:  Shannon M Hawkins; Gregory M Buchold; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2011-05-05

Review 6.  The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.

Authors:  Raquel Domingo-Fernandez; Karen Watters; Olga Piskareva; Raymond L Stallings; Isabella Bray
Journal:  Pediatr Surg Int       Date:  2012-12-29       Impact factor: 1.827

7.  Anti-correlation between longevity gene SirT1 and Notch signaling in ascending aorta biopsies from patients with bicuspid aortic valve disease.

Authors:  Sergio Sciacca; Michele Pilato; Gianluigi Mazzoccoli; Valerio Pazienza; Manlio Vinciguerra
Journal:  Heart Vessels       Date:  2012-02-28       Impact factor: 2.037

8.  Expression Profile of Selected MicroRNAs in the Peripheral Blood of Multiple Sclerosis Patients: a Multivariate Statistical Analysis with ROC Curve to Find New Biomarkers for Fingolimod.

Authors:  Mohammad Mahdi Eftekharian; Alireza Komaki; Mehrdokht Mazdeh; Shahram Arsang-Jang; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2019-03-21       Impact factor: 3.444

Review 9.  Epigenetics and cervical cancer: from pathogenesis to therapy.

Authors:  Jinchuan Fang; Hai Zhang; Sufang Jin
Journal:  Tumour Biol       Date:  2014-02-20

10.  Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells.

Authors:  Karthik Subramanian Chandrasekaran; Anusha Sathyanarayanan; Devarajan Karunagaran
Journal:  Tumour Biol       Date:  2016-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.